David Friedman

Professor and Director, Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland

Friedman is known for his contributions to the study of the mechanisms, epidemiology and prevention of angle-closure glaucoma. He has also greatly advanced the knowledge of patient medication adherence, being the principal investigator of the first trial to show that interventions, such as better educating patients and implementing systems to remind them to take medication, can successfully improve use of eye medicines. Friedman is the recipient of various awards from the National Institutes of Health, Research to Prevent Blindness and the American Geriatric Society, and co-edited what many consider to be the definitive book on angle-closure glaucoma.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016